Literature DB >> 19680634

Effects of MDMA on sociability and neural response to social threat and social reward.

Gillinder Bedi1, K Luan Phan, Mike Angstadt, Harriet de Wit.   

Abstract

RATIONALE: +/-3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") reportedly produces unique subjective effects, including increased sociability, feelings of closeness with others, and reduced interpersonal defensiveness. Despite their apparent importance in recreational and potential psychotherapeutic use of MDMA, the defining characteristics and neurobiological mechanisms of these interpersonal effects are poorly understood.
MATERIALS AND METHODS: We investigated acute effects of MDMA on self-reported sociability and neuronal activation in response to socially threatening (angry and fearful faces) and socially rewarding (happy faces) stimuli. Assessment of social threat response focused on amygdala activation, whereas assessment of social reward focused on ventral striatum activation. Healthy volunteers (N = 9) reporting past ecstasy use completed three experimental sessions, receiving MDMA (0.75 and 1.5 mg/kg) and placebo (PBO) under double-blind conditions. During peak drug effects, participants underwent functional magnetic resonance imaging while viewing standardized images depicting emotional facial expressions including angry, fearful, happy, and neutral expressions. They also completed standardized self-report measures of sociability.
RESULTS: MDMA (1.5 mg/kg) increased self-reported sociability compared to MDMA (0.75 mg/kg) and PBO. MDMA (1.5 mg/kg) attenuated left amygdala response to angry facial expressions compared to PBO, but MDMA did not affect amygdala reactivity to fearful expressions. MDMA (0.75 mg/kg) enhanced ventral striatum response to happy expressions relative to PBO.
CONCLUSIONS: These data present the first evidence that MDMA may increase sociability in humans both by diminishing responses to threatening stimuli and enhancing responses to rewarding social signals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680634      PMCID: PMC3328967          DOI: 10.1007/s00213-009-1635-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  50 in total

1.  Dextroamphetamine modulates the response of the human amygdala.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Francesco Fera; William G Smith; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2002-12       Impact factor: 7.853

Review 2.  Dopaminergic-neuropeptide interactions in the social brain.

Authors:  David H Skuse; Louise Gallagher
Journal:  Trends Cogn Sci       Date:  2008-12-10       Impact factor: 20.229

3.  The content of ecstasy tablets: implications for the study of their long-term effects.

Authors:  Jon C Cole; Mike Bailey; Harry R Sumnall; Graham F Wagstaff; Les A King
Journal:  Addiction       Date:  2002-12       Impact factor: 6.526

Review 4.  The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels.

Authors:  Simon N Young; Marco Leyton
Journal:  Pharmacol Biochem Behav       Date:  2002-04       Impact factor: 3.533

5.  Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.

Authors:  M E Liechti; M R Saur; A Gamma; D Hell; F X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2000-10       Impact factor: 7.853

6.  3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans.

Authors:  A Gamma; A Buck; T Berthold; M E Liechti; F X Vollenweider; D Hell
Journal:  Neuropsychopharmacology       Date:  2000-10       Impact factor: 7.853

7.  Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects.

Authors:  J Cami; M Farré; M Mas; P N Roset; S Poudevida; A Mas; L San; R de la Torre
Journal:  J Clin Psychopharmacol       Date:  2000-08       Impact factor: 3.153

8.  Serotonergic intervention affects both social dominance and affiliative behaviour.

Authors:  Wai S Tse; Alyson J Bond
Journal:  Psychopharmacology (Berl)       Date:  2002-04-04       Impact factor: 4.530

Review 9.  (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.

Authors:  U D McCann; V Eligulashvili; G A Ricaurte
Journal:  Neuropsychobiology       Date:  2000       Impact factor: 2.328

10.  Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.

Authors:  Debra S Harris; Matthew Baggott; Jack H Mendelson; John E Mendelson; Reese T Jones
Journal:  Psychopharmacology (Berl)       Date:  2002-06-27       Impact factor: 4.530

View more
  65 in total

1.  Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Authors:  Christina R Di Iorio; Tristan J Watkins; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Baxter Rogers; Mohammed S Ansari; Ronald M Baldwin; Rui Li; Robert M Kessler; Ronald M Salomon; Margaret Benningfield; Ronald L Cowan
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

Review 2.  The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.

Authors:  Philip Kamilar-Britt; Gillinder Bedi
Journal:  Neurosci Biobehav Rev       Date:  2015-09-25       Impact factor: 8.989

3.  Expressive suppression and neural responsiveness to nonverbal affective cues.

Authors:  Raluca Petrican; R Shayna Rosenbaum; Cheryl Grady
Journal:  Neuropsychologia       Date:  2015-09-10       Impact factor: 3.139

4.  'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content.

Authors:  Margaret C Wardle; Matthew G Kirkpatrick; Harriet de Wit
Journal:  Soc Cogn Affect Neurosci       Date:  2014-03-27       Impact factor: 3.436

5.  MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions.

Authors:  Cédric M Hysek; Gregor Domes; Matthias E Liechti
Journal:  Psychopharmacology (Berl)       Date:  2012-01-27       Impact factor: 4.530

6.  Amygdala abnormalities in first-degree relatives of individuals with schizophrenia unmasked by benzodiazepine challenge.

Authors:  Daniel H Wolf; Theodore D Satterthwaite; James Loughead; Amy Pinkham; Eve Overton; Mark A Elliott; Gersham W Dent; Mark A Smith; Ruben C Gur; Raquel E Gur
Journal:  Psychopharmacology (Berl)       Date:  2011-05-21       Impact factor: 4.530

Review 7.  Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

Authors:  Lee E Dunlap; Anne M Andrews; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-07-12       Impact factor: 4.418

8.  MDMA does not alter responses to the Trier Social Stress Test in humans.

Authors:  Anya K Bershad; Melissa A Miller; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2017-04-21       Impact factor: 4.530

9.  MDMA enhances emotional empathy and prosocial behavior.

Authors:  Cédric M Hysek; Yasmin Schmid; Linda D Simmler; Gregor Domes; Markus Heinrichs; Christoph Eisenegger; Katrin H Preller; Boris B Quednow; Matthias E Liechti
Journal:  Soc Cogn Affect Neurosci       Date:  2013-10-04       Impact factor: 3.436

10.  Effects of oxycodone on brain responses to emotional images.

Authors:  Margaret C Wardle; Daniel A Fitzgerald; Michael Angstadt; Christine A Rabinak; Harriet de Wit; K Luan Phan
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.